大麻素受体2 (CB2) 调节器:专利审查 (2016-2024)
Rayees Ahmad Naikoo1, Ritu Painuli1, Zaheen Akhter2
1Natural Product & Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India.
Bioorganic chemistry
|September 17, 2024
概括
对CB2受体调节器的新研究,专注于选择性联结体,显示出治疗疼痛,炎症和各种疾病的前景. 在CB2激动剂和抗剂方面的进展正在为新型疗法铺平道路.
科学领域:
- 药理学和药物化学 药理学和药物化学
- 神经科学是一个神经科学.
- 药物发现 药物发现 药物发现
背景情况:
- 大麻素受体 (CB1和CB2) 调节重要生理功能.
- CB1受体连接体因心理副作用而面临限制,重点转移到CB2特异性药物.
- 现有的CB2配体缺乏足够的选择性,阻碍了临床批准.
研究的目的:
- 从2016年到2024年,审查关于CB2调节器的专利文献.
- 为了突出选择性CB2受体配体的进步.
- 探索CB2调节器的治疗应用和未来前景.
主要方法:
- 关于CB2调节器的专利文献的全面审查.
- 在指定的时间内分析研究趋势和治疗目标.
- 鉴定CB2激动剂和对抗剂研究中的关键发展.
主要成果:
- 显著的专利活动集中在CB2调节器,用于炎症和缓解疼痛.
- 探索CB2调节器用于各种疾病,包括精神疾病,癌症,神经退行性疾病等.
- 对CB2抗剂/逆agonists的兴趣越来越大,尽管更少的人已经达到临床研究.
结论:
- 在合成和调节选择性CB2激动剂和抗剂方面取得了实质性的进展.
- CB2调节器显示出广泛的治疗应用的潜力.
- 预计CB2向疗法的持续发展.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
204
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
204
G Protein-coupled Receptors
11.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.5K
Opioid Receptors: Overview
584
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
584
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Analgesia and Pain Management
551
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
551
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K


